Trial Profile
Pilot study of oral 852A for elimination of high-grade dysplasia in Barrett's esophagus
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 May 2018
Price :
$35
*
At a glance
- Drugs 852A (Primary)
- Indications Barrett's oesophagus
- Focus Therapeutic Use
- 20 Dec 2006 New trial record.